Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases

被引:3
|
作者
Wu, Yinuo [1 ]
Ma, Biao [2 ]
Liu, Chang [2 ]
Li, Dangdang [2 ]
Sui, Guangchao [2 ]
机构
[1] Northeast Forestry Univ, Aulin Coll, Harbin 150040, Peoples R China
[2] Northeast Forestry Univ, Coll Life Sci, Harbin 150040, Peoples R China
基金
中国国家自然科学基金;
关键词
neurodegenerative diseases; phase separation and aggregation; pathology; treatment; AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; AMYLOID BETA-PROTEIN; DIPEPTIDE-REPEAT PROTEINS; SPINAL MUSCULAR-ATROPHY; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; SUPEROXIDE-DISMUTASE; RNA-BINDING; MOLECULAR TWEEZERS;
D O I
10.3390/ijms251810187
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurodegenerative diseases are the leading cause of human disability and immensely reduce patients' life span and quality. The diseases are characterized by the functional loss of neuronal cells and share several common pathogenic mechanisms involving the malfunction, structural distortion, or aggregation of multiple key regulatory proteins. Cellular phase separation is the formation of biomolecular condensates that regulate numerous biological processes, including neuronal development and synaptic signaling transduction. Aberrant phase separation may cause protein aggregation that is a general phenomenon in the neuronal cells of patients suffering neurodegenerative diseases. In this review, we summarize the pathological causes of common neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease, among others. We discuss the regulation of key amyloidogenic proteins with an emphasis of their aberrant phase separation and aggregation. We also introduce the approaches as potential therapeutic strategies to ameliorate neurodegenerative diseases through intervening protein aggregation. Overall, this review consolidates the research findings of phase separation and aggregation caused by misfolded proteins in a context of neurodegenerative diseases.
引用
收藏
页数:34
相关论文
共 50 条
  • [21] Methods and models in neurodegenerative and systemic protein aggregation diseases
    Brorsson, Ann-Christin
    Kumita, Janet R.
    MacLeod, Ian
    Bolognesi, Benedetta
    Speretta, Elena
    Luheshi, Leila M.
    Knowles, Tuomas P. J.
    Lomas, David A.
    Dobson, Christopher M.
    Crowther, Damian C.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2010, 15 : 373 - 396
  • [22] Protein aggregation and its affecting mechanisms in neurodegenerative diseases
    Wu, Junyun
    Wu, Jianan
    Chen, Tao
    Cai, Jing
    Ren, Reng
    NEUROCHEMISTRY INTERNATIONAL, 2024, 180
  • [23] Biochemical and immunological aspects of protein aggregation in neurodegenerative diseases
    Shojaei, Fatemeh
    Tavakolinia, Naemeh
    Divsalar, Adeleh
    Haertle, Thomas
    Saboury, Ali Akbar
    Nemat-Gorgani, Mohsen
    Abbracchio, Maria Pia
    JOURNAL OF THE IRANIAN CHEMICAL SOCIETY, 2014, 11 (06) : 1503 - 1512
  • [24] New insights of poly(ADP-ribosylation) in neurodegenerative diseases: A focus on protein phase separation and pathologic aggregation
    Liu, Cong
    Fang, Yanshan
    BIOCHEMICAL PHARMACOLOGY, 2019, 167 : 58 - 63
  • [25] Protein recycling pathways in neurodegenerative diseases
    Fecto, Faisal
    Esengul, Y. Taylan
    Siddique, Teepu
    ALZHEIMERS RESEARCH & THERAPY, 2014, 6 (02):
  • [26] Beyond aggregation: Pathological phase transitions in neurodegenerative disease
    Mathieu, Cecile
    Pappu, Rohit, V
    Taylor, J. Paul
    SCIENCE, 2020, 370 (6512) : 56 - 60
  • [27] Congo red and protein aggregation in neurodegenerative diseases
    Frid, Petrea
    Anisimov, Sergey V.
    Popovic, Natalija
    BRAIN RESEARCH REVIEWS, 2007, 53 (01) : 135 - 160
  • [28] Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases
    Cruz-Haces, Marcela
    Tang, Jonathan
    Acosta, Glen
    Fernandez, Joseph
    Shi, Riyi
    TRANSLATIONAL NEURODEGENERATION, 2017, 6
  • [29] Non-enzymatic posttranslational protein modifications in protein aggregation and neurodegenerative diseases
    Baldensperger, Tim
    Preissler, Miriam
    Becker, Christian F. W.
    RSC CHEMICAL BIOLOGY, 2025, 6 (02): : 129 - 149
  • [30] Proteinopathies, neurodegenerative disorders with protein aggregation-based pathology
    Shelkovnikova, T. A.
    Kulikova, A. A.
    Tsvetkov, Ph O.
    Peters, O.
    Bachurin, S. O.
    Buchman, V. L.
    Ninkina, N. N.
    MOLECULAR BIOLOGY, 2012, 46 (03) : 362 - 374